Hospital for Special Care Extends Altera Digital Health Partnership
Long-term acute care hospital on Sunrise EHR will also deploy Sunrise Health Record Altera Digital Health, a global health IT leader, today announced that Hospital for...
Category : Healthcare and Pharmaceutical
Elegen Launches ENFINIA™ IVT Ready DNA to Speed mRNA Synthesis
Elegen’s cell-free gene synthesis platform delivers full-length, high-complexity linear DNA with encoded poly(A) tails up to three times faster and free from bioburden, endotoxins and...
Valo Health Awarded Grant to Advance Parkinson’s Disease Research
Valo to leverage human causal biology expertise to uncover new insights about NOD2 as a potential Parkinson’s disease drug target Valo Health, Inc. (“Valo”), a company...
Tempus Study Validates PurIST® Algorithm for Pancreatic Cancer Therapy
Real-world evidence demonstrates PurIST’s ability to guide first-line treatment decisions and improve outcomes for patients with advanced pancreatic ductal adenocarcinoma (PDAC) Tempus AI, Inc. (NASDAQ:...
Vyome Holdings Adds Industry Veterans as It Plans Pivotal Trial Studies
Dr. Richard Fahrner and Dr. Tamara Agajanov add expertise in accelerated approvals Vyome Holdings, Inc. (NASDAQ: HIND), a clinical-stage healthcare holding company, today announced the...
Greenspace Health Hosts Panel on Strengthening Child Behavioral Health
Webinar will prepare providers for updated CARF accreditation standards and share strategies to improve outcomes for young people Greenspace Health, North America’s leading provider of...
Agile4Vets LLC Wins VA Contract to Transform Veteran Healthcare Services
Navvis brings proven healthcare transformation expertise to accelerate high-performance, value-based care delivery for veterans nationwide Navvis, the leading value-based care enablement company, is proud to...
Bausch + Lomb Launches ASANA Gas Permeable Lenses in U.S.
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S....
Precision BioSciences Secures U.S. Patent for PBGENE-HBV
Strengthens the Company’s intellectual property portfolio for lead in vivo program PBGENE-HBV with U.S. patent protection into 2042 Phase 1 ELIMINATE-B trial progressing through clinical...
Regeneron Reports Positive Phase 3 Data for Allergy Antibodies
In separate cat and birch allergen-challenge trials, single doses of allergen-specific antibody blockers significantly reduced allergy symptoms compared to placebo Data from these trials will...
IDEAYA Reports Positive Phase 2 Data for Darovasertib in UM
IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, will present positive interim data at their 10-Year Anniversary R&D Day from their ongoing Phase...
Lilly’s Jaypirca Improves Survival in CLL/SLL Patients
In the Phase 3 BRUIN CLL-313 study, treatment with pirtobrutinib demonstrated a highly statistically significant and clinically meaningful improvement in progression-free survival versus bendamustine plus rituximab,...
FDA Accepts LSM by VCTE as Surrogate Endpoint in MASH Trials
This milestone opens a path for FibroScan® to ultimately replace liver biopsy for patient enrollment and treatment response assessment in MASH drug development Echosens, the leader...
Gushengtang’s H1 2025 Profit Up 41.6% on Digital Health Growth
On August 29, Gushengtang (HKG:2273) announced its interim results for 2025, reporting strong operational and financial performance. The company posted revenue of RMB 1.49 billion, representing a...
Prime Healthcare Earns National Heart Association Awards
Hospitals earn national awards for stroke, heart failure, and cardiovascular care, including recognition with the new Commitment to Quality Award Key Highlights The American Heart...